Top Stories
-
Charles Johnson, founder of 4Kira4Moms, delivered an inspiring and passionate presentation to the Ob/Gyn department.
Topic
-
#BehindtheMask is a series that spotlights the faculty, staff, and trainees in our department. Today, meet June Hou, MD.
-
Faculty, fellows, residents, and medical students from Columbia University presented at 2022 Meeting for the Society of Gynecologic Surgeons.
-
Learn more about treatment for endometriosis, such as fertility-sparing surgeries and optimization of medical therapies.
Browse by Topics
Women's Health
- July 15, 2022
Learn more about treatment of uterine fibroids during this informational webinar from Columbia Ob/Gyn.
Topic
-
Source:
The Washington PostJuly 9, 2022The Supreme Court’s overturning of Roe v. Wade has brought a flurry of changes to abortion laws.
Topic
-
Source:
U.S. News and World ReportJune 29, 2022Shortly after news broke that Roe v. Wade was in danger of being overturned, internet searches for abortion pills surged.
Topic
Fertility
- November 19, 2018
A revolutionary treatment option for iVF, developed by the team at Columbia Fertility could give hope to many who have not found success with traditional IVF – at a fraction of the cost.
Topic
-
Source:
ForbesSeptember 20, 2022Surrogacy is becoming an increasingly common family-building option that offers a beacon of hope for people.
Topic
-
Source:
TIME MagazineSeptember 8, 2022Each year, tens of thousands of people in the U.S. try to conceive using in vitro fertilization (IVF).
Topic
High-Risk Pregnancy
- September 6, 2018
Babies are “due” after 40 weeks of gestation, but evidence suggests that infant mortality and complications are lowest for those delivered at 39 weeks, when a fetus is considered full term
Topic
-
Source:
ProPublicaAugust 14, 2018From the Mayo Clinic to Harvard, sources don't always get the facts right about preeclampsia. Reached by ProPublica, some are making needed corrections.
Topic
-
Source:
ForbesSeptember 20, 2018This morning, Alydia Health announced that it has secured $10 million in funding to test a medical device to prevent mothers from bleeding to death after childbirth.
Topic
